Clinical Trial Update: Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring micro-dosing psychedelics for frontline healthcare workers with acute stress disorder during the COVID-19 pandemic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Disorder

Snippet

Sponsor: Limbic Medical | Conditions: Acute Stress Disorder | Phase 4 | Status: UNKNOWN